BOREALIS Trademark

Trademark Overview

On Wednesday, May 19, 2021, a trademark application was filed for BOREALIS with the United States Patent and Trademark Office. The USPTO has given the BOREALIS trademark a serial number of 90720612. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Wednesday, March 29, 2023. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The BOREALIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
borealis

General Information

Serial Number90720612
Word MarkBOREALIS
Filing DateWednesday, May 19, 2021
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateWednesday, March 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of of "BOREALIS" in dark blue with three triangles above the letters "LIS"-- one being green, light green, and dark green, one being blue, light blue, and dark blue, and one being purple, light purple, and dark purple.
Indication of Colors claimedThe color(s) dark purple, purple, light purple, blue, light blue, dark blue, green, light green, and dark green is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Monday, April 3, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Wednesday, March 29, 2023ABANDONMENT - AFTER EX PARTE APPEAL
Wednesday, March 29, 2023EXPARTE APPEAL TERMINATED
Wednesday, March 29, 2023EXPARTE APPEAL TERMINATED
Wednesday, March 29, 2023EXPARTE APPEAL DISMISSED
Wednesday, February 15, 2023NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, February 15, 2023ACTION DENYING REQ FOR RECON E-MAILED
Wednesday, February 15, 2023ACTION CONTINUING FINAL - COMPLETED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 16, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 16, 2023EX PARTE APPEAL-INSTITUTED
Monday, January 16, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 16, 2023EXPARTE APPEAL RECEIVED AT TTAB
Thursday, July 14, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 14, 2022FINAL REFUSAL E-MAILED
Thursday, July 14, 2022FINAL REFUSAL WRITTEN
Thursday, June 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 16, 2021NON-FINAL ACTION E-MAILED
Thursday, December 16, 2021NON-FINAL ACTION WRITTEN
Tuesday, December 14, 2021ASSIGNED TO EXAMINER
Wednesday, August 18, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 22, 2021NEW APPLICATION ENTERED

Related Keywords

borealis pharmaceuticals field research scientific information trials medical clinical testing development